Subdominant/Cryptic CD8 T Cell Epitopes Contribute to Resistance against Experimental Infection with a Human Protozoan Parasite

During adaptive immune response, pathogen-specific CD8+ T cells recognize preferentially a small number of epitopes, a phenomenon known as immunodominance. Its biological implications during natural or vaccine-induced immune responses are still unclear. Earlier, we have shown that during experimental infection, the human intracellular pathogen Trypanosoma cruzi restricts the repertoire of CD8+ T cells generating strong immunodominance. We hypothesized that this phenomenon could be a mechanism used by the parasite to reduce the breath and magnitude of the immune response, favoring parasitism, and thus that artificially broadening the T cell repertoire could favor the host. Here, we confirmed our previous observation by showing that CD8+ T cells of H-2a infected mice recognized a single epitope of an immunodominant antigen of the trans-sialidase super-family. In sharp contrast, CD8+ T cells from mice immunized with recombinant genetic vaccines (plasmid DNA and adenovirus) expressing this same T. cruzi antigen recognized, in addition to the immunodominant epitope, two other subdominant epitopes. This unexpected observation allowed us to test the protective role of the immune response to subdominant epitopes. This was accomplished by genetic vaccination of mice with mutated genes that did not express a functional immunodominant epitope. We found that these mice developed immune responses directed solely to the subdominant/cryptic CD8 T cell epitopes and a significant degree of protective immunity against infection mediated by CD8+ T cells. We concluded that artificially broadening the T cell repertoire contributes to host resistance against infection, a finding that has implications for the host-parasite relationship and vaccine development.

[1]  B. Graham,et al.  Responses against a Subdominant CD8+ T Cell Epitope Protect against Immunopathology Caused by a Dominant Epitope , 2010, The Journal of Immunology.

[2]  D. Bartholomeu,et al.  The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease , 2010, Expert Reviews in Molecular Medicine.

[3]  E. Malchiodi,et al.  Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection. , 2010, The Journal of infectious diseases.

[4]  R. Tarleton,et al.  CD8+ T Cells Specific for Immunodominant Trans-Sialidase Epitopes Contribute to Control of Trypanosoma cruzi Infection but Are Not Required for Resistance , 2010, The Journal of Immunology.

[5]  P. Doherty,et al.  Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. , 2010, The Journal of clinical investigation.

[6]  F. Tzelepis,et al.  Impaired Innate Immunity in Tlr4 −/− Mice but Preserved CD8+ T Cell Responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-Deficient Mice , 2010, PLoS pathogens.

[7]  H. Ploegh,et al.  Differential Regulation of Effector- and Central-Memory Responses to Toxoplasma gondii Infection by IL-12 Revealed by Tracking of Tgd057-Specific CD8+ T Cells , 2010, PLoS pathogens.

[8]  C. Takiya,et al.  Trypanosoma cruzi Subverts Host Cell Sialylation and May Compromise Antigen-specific CD8+ T Cell Responses* , 2010, The Journal of Biological Chemistry.

[9]  A. Silber,et al.  Chagas’ disease: an update on immune mechanisms and therapeutic strategies , 2010, Journal of cellular and molecular medicine.

[10]  L. Rénia,et al.  A Role for Immune Responses against Non-CS Components in the Cross-Species Protection Induced by Immunization with Irradiated Malaria Sporozoites , 2009, PloS one.

[11]  R. Gazzinelli,et al.  The role of parasite persistence in pathogenesis of Chagas heart disease , 2009, Parasite immunology.

[12]  F. Tzelepis,et al.  Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. , 2009, Vaccine.

[13]  D. McKeever,et al.  CD8+ T-cell responses to Theileria parva are preferentially directed to a single dominant antigen: Implications for parasite strain-specific immunity , 2009, European Journal of Immunology.

[14]  R. Gazzinelli,et al.  Perforin and Gamma Interferon Expression Are Required for CD4+ and CD8+ T-Cell-Dependent Protective Immunity against a Human Parasite, Trypanosoma cruzi, Elicited by Heterologous Plasmid DNA Prime-Recombinant Adenovirus 5 Boost Vaccination , 2009, Infection and Immunity.

[15]  K. Lamberth,et al.  Elimination of Immunodominant Epitopes from Multispecific DNA-Based Vaccines Allows Induction of CD8 T Cells That Have a Striking Antiviral Potential1 , 2009, The Journal of Immunology.

[16]  C. Paiva,et al.  Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors--how to make a dream come true. , 2009, Memorias do Instituto Oswaldo Cruz.

[17]  J. Scharfstein,et al.  Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research. , 2009, Memorias do Instituto Oswaldo Cruz.

[18]  Stefan Tenzer,et al.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. , 2009, Nature immunology.

[19]  F. Tzelepis,et al.  Immunodominance: a new hypothesis to explain parasite escape and host/parasite equilibrium leading to the chronic phase of Chagas' disease? , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[20]  A. Ochsenbein,et al.  CTL induction by cross‐priming is restricted to immunodominant epitopes , 2009, European journal of immunology.

[21]  H. Ploegh,et al.  Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. , 2008, The Journal of infectious diseases.

[22]  D. Engman,et al.  Chagas heart disease pathogenesis: one mechanism or many? , 2008, Current molecular medicine.

[23]  L. Bixby,et al.  Stable CD8+ T Cell Memory during Persistent Trypanosoma cruzi Infection1 , 2008, The Journal of Immunology.

[24]  Bjoern Peters,et al.  Naive Precursor Frequencies and MHC Binding Rather Than the Degree of Epitope Diversity Shape CD8+ T Cell Immunodominance1 , 2008, The Journal of Immunology.

[25]  D. Watkins,et al.  Differential Antigen Presentation Kinetics of CD8+ T-Cell Epitopes Derived from the Same Viral Protein , 2008, Journal of Virology.

[26]  N. Shastri,et al.  Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum , 2008, Nature Immunology.

[27]  Y. Miyahira.  Erratum to “Trypanosoma cruzi infection from the view of CD8+ T cell immunity — An infection model for developing T cell vaccine” [Parasitology International 57 (2008) 38–48] , 2008 .

[28]  M. Munks,et al.  Subdominant CD8 T-Cell Epitopes Account for Protection against Cytomegalovirus Independent of Immunodomination , 2008, Journal of Virology.

[29]  Y. Miyahira.  Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine. , 2008, Parasitology international.

[30]  F. Tzelepis,et al.  Infection with Trypanosoma cruzi Restricts the Repertoire of Parasite-Specific CD8+ T Cells Leading to Immunodominance1 , 2008, The Journal of Immunology.

[31]  D. Busch,et al.  Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination , 2007, The Journal of experimental medicine.

[32]  R. Tarleton.  Immune system recognition of Trypanosoma cruzi. , 2007, Current opinion in immunology.

[33]  S. Boscardin,et al.  Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruzi. , 2007, Microbes and infection.

[34]  F. Tzelepis,et al.  Modulation of CD4+ T Cell-Dependent Specific Cytotoxic CD8+ T Cells Differentiation and Proliferation by the Timing of Increase in the Pathogen Load , 2007, PloS one.

[35]  B. Maciel,et al.  Pathogenesis of Chronic Chagas Heart Disease , 2007, Circulation.

[36]  D. Watkins,et al.  Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication , 2007, Journal of Virology.

[37]  M. Nussenzweig,et al.  The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites , 2006, Nature.

[38]  J. Yewdell,et al.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. , 2006, Immunity.

[39]  R. Gazzinelli,et al.  Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase. , 2006, Human gene therapy.

[40]  R. Webby,et al.  Addition of a Prominent Epitope Affects Influenza A Virus-Specific CD8+ T Cell Immunodominance Hierarchies When Antigen Is Limiting1 , 2006, The Journal of Immunology.

[41]  P. Marrack,et al.  CD8 T cell competition for dendritic cells in vivo is an early event in activation , 2006, Proceedings of the National Academy of Sciences.

[42]  Alessandro Sette,et al.  CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes , 2006, PLoS pathogens.

[43]  F. Tzelepis,et al.  Distinct Kinetics of Effector CD8+ Cytotoxic T Cells after Infection with Trypanosoma cruzi in Naïve or Vaccinated Mice , 2006, Infection and Immunity.

[44]  R. Webby,et al.  A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Schmitz,et al.  Monkeys Immunodeficiency Virus-infected Rhesus Lymphocyte Responses in Simian T + Dominant Epitope-specific Cd8 Immunodomination in the Evolution Of , 2022 .

[46]  K. Irvine,et al.  Factors influencing immunodominance hierarchies in TCD8+-mediated antiviral responses , 2006, Expert review of clinical immunology.

[47]  F. Kierszenbaum.  Where do we stand on the autoimmunity hypothesis of Chagas disease? , 2005, Trends in parasitology.

[48]  R. Gazzinelli,et al.  CD8+-T-Cell-Dependent Control of Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain after Immunization with Recombinant Proteins Based on Amastigote Surface Protein 2 , 2005, Infection and Immunity.

[49]  R. Gazzinelli,et al.  Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. , 2004, Human gene therapy.

[50]  S. Hoffman,et al.  Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Marion Becker,et al.  Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara , 1998, Nature Medicine.

[52]  J. Manuguerra,et al.  Protection against lethal viral infection by vaccination with nonimmunodominant peptides. , 1996, Journal of immunology.

[53]  J. Yewdell,et al.  Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. , 1994, Journal of immunology.

[54]  P. Palese,et al.  Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. Romero,et al.  The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules , 1992, The Journal of experimental medicine.

[56]  J. McCluskey,et al.  Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines. , 2006, Advances in cancer research.

[57]  W Chen,et al.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. , 2000, Immunity.